Back to Journals » Neuropsychiatric Disease and Treatment » Volume 11

A 6-year open-label study of the efficacy and safety of olanzapine long-acting injection in patients with schizophrenia: a post hoc analysis based on the European label recommendation

Total article views   HTML views PDF downloads Totals
13,880 Dovepress* 12,768+ 1,592 14,360
PubMed Central* 1,112 391 1,503
Totals 13,880 1,983 15,863
*Since 27 May 2015
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
8 1 0 0 3 4

View citations on PubMed Central and Google Scholar